In this Panel Discussion we assemble experts from across the spectrum of cancer research to explain how they use these techniques in their research, provide key tips for best practice when using them ...

The current generation of monoclonal antibodies is ineffective against the predominant variants of SARS-CoV-2 in circulation. Recent studies by Callaway et al. open the possibility that a new type of ...

SAN DIEGO--(BUSINESS WIRE)--Proteintech Genomics, a leader in antibody-based multiplexed solutions for single-cell multiomics, today announced the launch of its MultiPro® Human Discovery Panel, a ...

PHILADELPHIA, June 17, 2025 /PRNewswire/ -- Integral Molecular, the industry leader in discovering antibodies against membrane proteins, is pleased to announce that it has out-licensed a panel of ...

Monoclonal antibodies (mAbs) are one of the most successful therapeutic drug classes, generating lucrative sales for the pharmaceutical industry. In 2016, more than 20 therapeutic antibodies gained ...

In a recent study posted to the bioRxiv*preprint server, researchers isolated a large panel of broadly neutralizing antibodies (bnAbs) from coronavirus disease 2019 (COVID-19) recovered-vaccinated ...

An independent advisory committee to the Food and Drug Administration voted Thursday to recommend an injectable drug that can protect infants up to 2 years old from RSV. The 21-person panel voted ...